The Ceftizoxime Injection, cataloged under National Stock Number 6505-01-274-9670, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Astellas Pharma Us, Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-274-9670 |
| Primary Part Number | NDC00469-7221-02 |
| Item Name | Ceftizoxime Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Astellas Pharma Us, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Supplementary Features | 2GM CEFTIZOMINE EQUIVALENT; 50ML IN BAG W/HANGING DEVICE; PLASTIC; 24 BAGS PER PACKAGE; PREMIXED IN 5% DEXTROXE (D5W); FROZEN; SINGLE DOSE; BAGS W/HANGER STRAP |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BAG WITH HANGING DEVICE, PLASTIC |
| Protective Storage Feature | MUST BE FROZEN |
| Active Medicament Medicinal Strength | 2.000 GRAMS CEFTIZOXIME EQUIVALENT G |
| Total Primary Container Quantity | 24 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00469-7221-02 PRIMARY | Astellas Pharma Us, Inc. (USA) |
| 2B3515 PRIMARY | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
| Reference | Meaning |
|---|---|
| NDC57317-0221-50 | 5/9 Secondary reference Astellas Pharma Us, Inc. |
| CEFIZOX | 5/1 Secondary reference Astellas Pharma Us, Inc. |
NSN 6505-01-274-9670 is a Ceftizoxime Injection, manufactured by Astellas Pharma Us, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-274-9670 has 2 manufacturer part numbers on file: NDC00469-7221-02 (Astellas Pharma Us, Inc.), 2B3515 (Baxter Healthcare Corp IV Systems/gov Sales).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-350-0359. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00469-7221-02: Primary Container Content Quantity: 50.000 MILLILITERS; Supplementary Features: 2GM CEFTIZOMINE EQUIVALENT; 50ML IN BAG W/HANGING DEVICE; PLASTIC; 24 BAGS PER PACKAGE; PREMIXED IN 5% DEXTROXE (D5W); FROZEN; SINGLE DOSE; BAGS W/HANGER STRAP; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BAG WITH HANGING DEVICE, PLASTIC. 7 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.